Samantha Semenkow
Stock Analyst at Citigroup
(1.01)
# 3,838
Out of 4,996 analysts
47
Total ratings
33.33%
Success rate
-15.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Samantha Semenkow
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHVN Biohaven | Initiates: Buy | $28 | $15.00 | +86.67% | 1 | Sep 17, 2025 | |
| ROIV Roivant Sciences | Initiates: Buy | $16 | $15.17 | +5.47% | 1 | Sep 2, 2025 | |
| CABA Cabaletta Bio | Maintains: Buy | $13 → $10 | $2.36 | +323.73% | 4 | Aug 14, 2025 | |
| WVE Wave Life Sciences | Initiates: Buy | $16 | $6.80 | +135.29% | 1 | Jul 16, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | $10 → $1.5 | $5.12 | -70.70% | 3 | May 27, 2025 | |
| ALLO Allogene Therapeutics | Maintains: Buy | $8 → $4 | $1.25 | +220.00% | 3 | May 15, 2025 | |
| ARGX argenx SE | Maintains: Buy | $796 → $803 | $712.03 | +12.78% | 6 | May 9, 2025 | |
| GPCR Structure Therapeutics | Initiates: Buy | $60 | $25.00 | +140.00% | 1 | May 2, 2025 | |
| BIOA BioAge Labs | Maintains: Neutral | $7 → $5 | $5.42 | -7.75% | 3 | Mar 24, 2025 | |
| VYGR Voyager Therapeutics | Initiates: Buy | $12 | $4.52 | +165.49% | 1 | Dec 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $31 | $19.52 | +58.81% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $15 | $3.34 | +349.10% | 2 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $80 | $8.80 | +809.09% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $14 | $5.10 | +174.78% | 6 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $15 | $3.24 | +362.96% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $72 | $61.99 | +16.15% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $50 | $16.23 | +208.07% | 3 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $56 | $22.97 | +143.80% | 3 | Aug 9, 2023 |
Biohaven
Sep 17, 2025
Initiates: Buy
Price Target: $28
Current: $15.00
Upside: +86.67%
Roivant Sciences
Sep 2, 2025
Initiates: Buy
Price Target: $16
Current: $15.17
Upside: +5.47%
Cabaletta Bio
Aug 14, 2025
Maintains: Buy
Price Target: $13 → $10
Current: $2.36
Upside: +323.73%
Wave Life Sciences
Jul 16, 2025
Initiates: Buy
Price Target: $16
Current: $6.80
Upside: +135.29%
Prime Medicine
May 27, 2025
Downgrades: Neutral
Price Target: $10 → $1.5
Current: $5.12
Upside: -70.70%
Allogene Therapeutics
May 15, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.25
Upside: +220.00%
argenx SE
May 9, 2025
Maintains: Buy
Price Target: $796 → $803
Current: $712.03
Upside: +12.78%
Structure Therapeutics
May 2, 2025
Initiates: Buy
Price Target: $60
Current: $25.00
Upside: +140.00%
BioAge Labs
Mar 24, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $5.42
Upside: -7.75%
Voyager Therapeutics
Dec 2, 2024
Initiates: Buy
Price Target: $12
Current: $4.52
Upside: +165.49%
Aug 9, 2024
Maintains: Buy
Price Target: $27 → $31
Current: $19.52
Upside: +58.81%
Aug 9, 2024
Maintains: Buy
Price Target: $8 → $15
Current: $3.34
Upside: +349.10%
Jun 3, 2024
Reinstates: Buy
Price Target: $80
Current: $8.80
Upside: +809.09%
May 22, 2024
Maintains: Buy
Price Target: $10 → $14
Current: $5.10
Upside: +174.78%
May 9, 2024
Maintains: Buy
Price Target: $16 → $15
Current: $3.24
Upside: +362.96%
Dec 8, 2023
Initiates: Buy
Price Target: $72
Current: $61.99
Upside: +16.15%
Sep 27, 2023
Maintains: Buy
Price Target: $33 → $50
Current: $16.23
Upside: +208.07%
Aug 9, 2023
Maintains: Buy
Price Target: $60 → $56
Current: $22.97
Upside: +143.80%